PUBLISHER: The Business Research Company | PRODUCT CODE: 1948284
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948284
Structural heart devices are specialized medical implants or tools tailored for treating various structural defects or abnormalities affecting the heart. They are utilized to repair or replace damaged heart structures, such as valves or septa, thereby restoring normal heart functions and enhancing patient outcomes.
The primary types of structural heart devices include heart valve devices, annuloplasty rings, occluders, and delivery systems. Heart valve devices are medical tools crafted to repair or replace damaged heart valves, ensuring proper blood flow through the heart. These procedures encompass replacement procedures, repair procedures for indications such as atrial septal defect, patent foramen ovale, ventricular septal defect, aortic valve stenosis, and others, catering to age group categories including pediatrics and adults.
Tariffs are influencing the structural heart devices market by increasing costs of imported medical-grade alloys, polymers, precision catheters, and advanced manufacturing equipment used in valves, occluders, and delivery systems. North America and Europe are most affected due to reliance on cross-border sourcing of specialized components, while Asia-Pacific faces pricing pressure on device exports. These tariffs are raising overall procedure costs and impacting hospital procurement decisions. At the same time, they are driving localized manufacturing, regional clinical supply chains, and increased investment in domestic cardiovascular device production.
The structural heart devices market research report is one of a series of new reports from The Business Research Company that provides structural heart devices market statistics, including structural heart devices industry global market size, regional shares, competitors with a structural heart devices market share, detailed structural heart devices market segments, market trends and opportunities, and any further data you may need to thrive in the structural heart devices industry. This structural heart devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The structural heart devices market size has grown strongly in recent years. It will grow from $11.37 billion in 2025 to $12.48 billion in 2026 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to increasing prevalence of structural heart diseases, aging global population, early adoption of valve replacement technologies, expansion of cardiac specialty centers, improvements in interventional cardiology techniques.
The structural heart devices market size is expected to see strong growth in the next few years. It will grow to $17.23 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to increasing preference for minimally invasive procedures, rising investments in cardiovascular innovation, expansion of pediatric cardiac interventions, growing adoption of AI-assisted diagnostics, increasing demand for durable and long-lasting implants. Major trends in the forecast period include increasing adoption of transcatheter heart valve procedures, rising demand for minimally invasive cardiac implants, growing integration of advanced imaging and navigation systems, expansion of catheter-based delivery technologies, enhanced focus on patient-specific device design.
The increasing prevalence of cardiovascular diseases is expected to drive the growth of the structural heart device market in the coming years. Cardiovascular diseases (CVDs) encompass a range of conditions that affect the heart and blood vessels, such as coronary artery disease, heart attacks, and strokes. The global incidence of cardiovascular diseases, including heart disease and stroke, has been steadily rising, driven by factors such as sedentary lifestyles, poor diet, obesity, smoking, and aging populations. Structural heart devices are used to treat these diseases by repairing or replacing damaged heart valves, correcting structural defects, and enhancing heart function and patient outcomes. For example, in September 2024, the British Heart Foundation, a UK-based cardiovascular research charity, reported that approximately 7.6 million people in the UK are affected by heart and circulatory diseases, with 4 million males and 3.6 million females living with these conditions. These diseases account for about 27% of all deaths in the UK, resulting in over 170,000 deaths annually, or roughly 480 deaths per day, which equates to one death every three minutes. As a result, the growing prevalence of cardiovascular diseases is fueling the expansion of the structural heart device market.
Major companies in the structural heart devices market are focusing on developing advanced solutions, such as next-generation transcatheter heart valves, to enhance durability, minimize complications, and broaden minimally invasive treatment options. Next-generation transcatheter heart valves are replacement valves designed for minimally invasive procedures, incorporating features like anti-calcification tissue and improved sealing to extend durability and reduce risks compared to earlier models. For instance, in September 2025, Edwards Lifesciences Corporation, a US-based medical technology company, launched a next-generation transcatheter heart valve platform in India, providing a durable, minimally invasive treatment for aortic stenosis in patients ineligible for open-heart surgery. This valve features calcification-resistant tissue to prevent calcium buildup and prolong longevity, a taller outer sealing skirt to minimize paravalvular leaks, and dry tissue storage for easier hospital handling. Additionally, the platform supports a "lifetime management" strategy, enabling minimally invasive valve-in-valve procedures for future interventions and ensuring sustained treatment effectiveness.
In October 2024, Johnson & Johnson, a US-based healthcare technology company, acquired V-Wave Ltd. for an undisclosed amount. Through this acquisition, Johnson & Johnson aims to enhance its MedTech cardiovascular portfolio and accelerate its presence in high-growth heart-failure treatment markets. V-Wave Ltd. is an Israel-based medical device company specializing in structural heart devices.
Major companies operating in the structural heart devices market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., LivaNova PLC, Meril Life Sciences Pvt. Ltd., CryoLife Inc., Braile Biomedica, Direct Flow Medical Inc., JenaValve Technology Inc., Micro Interventional Devices Inc., CardioKinetix Inc., Xeltis AG, Ancora Heart Inc., JOMDD Inc., Valcare Medical, BioStable Science & Engineering Inc., Comed B.V., Transcatheter Technologies GmbH
North America was the largest region in the structural heart devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the structural heart devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The structural heart devices market consists of sales of paravalvular leak closure devices, endovascular stents, and percutaneous mitral valve replacement. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Structural Heart Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses structural heart devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for structural heart devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The structural heart devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.